Travere Therapeutics, Inc. · NASDAQ:TVTX
Reed Elizabeth E sold 51,500 Travere Therapeutics, Inc. shares (Form 4)
Traded Apr 13 to Apr 15, 2026 · Filed Apr 15, 2026
From Apr 13 to Apr 15, 2026, Reed Elizabeth E (Chief Legal Officer and GC) sold 51,500 Travere Therapeutics, Inc. shares at an average US$41.29 for US$2.13M under a trading plan, leaving 105,211 shares. Filed Apr 15, 2026 (Form 4).
- Sold
- 51,500 shares
- Price
- US$41.29 average (US$41.07 to US$42.53)
- Value
- US$2.13M
- Holding after
- 105,211 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Legal Officer and GC
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 13, 2026 | Common Stock | Award | 14,000 | 119,211 | Direct | |
| Apr 14, 2026 | Common Stock | Option exercise | 10,000 | US$19.08 | 129,211 | Direct |
| Apr 14, 2026 | Common Stock | Option exercise | 20,000 | US$17.96 | 149,211 | Direct |
| Apr 14, 2026 | Common Stock | Option exercise | 7,500 | US$15.46 | 156,711 | Direct |
| Apr 14, 2026 | Common Stock | Sale | 37,500 | US$41.07 | 119,211 | Direct |
| Apr 14, 2026 | Common Stock | Sale | 7,215 | US$41.93 | 111,996 | Direct |
| Apr 15, 2026 | Common Stock | Sale | 5,226 | US$41.62 | 106,770 | Direct |
| Apr 15, 2026 | Common Stock | Sale | 1,559 | US$42.53 | 105,211 | Direct |
Source
Related
- Travere Therapeutics, Inc.
- Reed Elizabeth E
- Travere Therapeutics, Inc. shareholders
- Form 4 · Reed Elizabeth E · Sep 17, 2026
- Form 4 · Reed Elizabeth E · May 6, 2026
- Form 4 · Reed Elizabeth E · Apr 2, 2026
- Form 4 · Dube Eric M · Oct 19, 2026
- Form 4 · Heerma Peter · Sep 17, 2026
- Form 4 · Dube Eric M · Sep 17, 2026
- Form 4 · Rote William E. · Sep 17, 2026
- Form 4 · Inrig Jula · Sep 17, 2026